273 related articles for article (PubMed ID: 35362188)
1. Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial.
Wang JB; Huang A; Wang Y; Ji D; Liang QS; Zhao J; Zhou G; Liu S; Niu M; Sun Y; Tian H; Teng GJ; Chang BX; Bi JF; Peng XX; Xin S; Xie H; Ma X; Mao YM; Liangpunsakul S; Saxena R; Aithal GP; Xiao XH; Zhao J; Zou Z
Aliment Pharmacol Ther; 2022 May; 55(10):1297-1310. PubMed ID: 35362188
[TBL] [Abstract][Full Text] [Related]
2. An optimized short-term steroid therapy for chronic drug-induced liver injury: A prospective randomized clinical trial.
Huang A; Zhu Y; Liu S; Sun Y; Liu Z; Liang QS; Zhao J; Chang BX; Bi JF; Liu JT; Zhai XR; Xie H; Li N; Tian H; Han L; Zhuang Y; Ma H; Teng GJ; Zhang W; Aithal GP; Ji D; Zhao J; Zou Z
Liver Int; 2024 Jun; 44(6):1435-1447. PubMed ID: 38483145
[TBL] [Abstract][Full Text] [Related]
3. Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).
Teschke R; Danan G
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33800917
[TBL] [Abstract][Full Text] [Related]
4. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
Weber S; Gerbes AL
Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
[TBL] [Abstract][Full Text] [Related]
5. Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.
Teschke R; Danan G
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446036
[TBL] [Abstract][Full Text] [Related]
6. Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.
Teschke R; Eickhoff A; Schulze J; Danan G
Transl Gastroenterol Hepatol; 2021; 6():51. PubMed ID: 34423172
[TBL] [Abstract][Full Text] [Related]
7. Editorial: chronic DILI and HILI - corticosteroid plus glycyrrhizin as standard therapy?
Teschke R; Eickhoff A
Aliment Pharmacol Ther; 2022 Jul; 56(1):166-167. PubMed ID: 35689326
[No Abstract] [Full Text] [Related]
8. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis.
Teschke R; Danan G
Medicines (Basel); 2020 Sep; 7(10):. PubMed ID: 33003400
[No Abstract] [Full Text] [Related]
9. RUCAM in Drug and Herb Induced Liver Injury: The Update.
Danan G; Teschke R
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712744
[TBL] [Abstract][Full Text] [Related]
10. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis.
Hisamochi A; Kage M; Ide T; Arinaga-Hino T; Amano K; Kuwahara R; Ogata K; Miyajima I; Kumashiro R; Sata M; Torimura T
J Gastroenterol; 2016 Jun; 51(6):597-607. PubMed ID: 26519284
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China.
Chen Y; Wang C; Yang H; Huang P; Shi J; Tong Y; Jiang J; Zhang X; Chen W; Xuan Z
Biomed Res Int; 2021; 2021():8894498. PubMed ID: 33954202
[TBL] [Abstract][Full Text] [Related]
12. Early ALT response to corticosteroid treatment distinguishes idiosyncratic drug-induced liver injury from autoimmune hepatitis.
Weber S; Benesic A; Rotter I; Gerbes AL
Liver Int; 2019 Oct; 39(10):1906-1917. PubMed ID: 31319011
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the efficacy and safety of compound glycyrrhizin injections in the treatment of drug-induced liver injury using a nationwide database.
Yao L; Zhang J; Jin J; Li H; Li L; Han X; Raza HK; Li X; Mao Y
Int J Clin Pharm; 2022 Jun; 44(3):731-740. PubMed ID: 35438473
[TBL] [Abstract][Full Text] [Related]
14. Editorial: chronic DILI and HILI-corticosteroid plus glycyrrhizin as standard therapy? Authors' reply.
Wang JB; Huang A; Wang Y; Ji D; Zou Z
Aliment Pharmacol Ther; 2022 Jul; 56(1):168-169. PubMed ID: 35689319
[No Abstract] [Full Text] [Related]
15. Immune-mediated herb-induced liver injury: a potential association with herbal artemisinin use as supported by the updated RUCAM.
Mathavan A; Mathavan A; Krekora U; Daily K
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37142282
[TBL] [Abstract][Full Text] [Related]
16. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Danan G; Teschke R
Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
[TBL] [Abstract][Full Text] [Related]
17. Herb-induced autoimmune-like hepatitis associated with Xiang-tian-guo (Swietenia macrophylla seeds): A case report and literature review.
Shao YM; Zhang Y; Yin X; Qin TT; Jin QL; Wen XY
Medicine (Baltimore); 2021 Jan; 100(2):e24045. PubMed ID: 33466156
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury.
Jing J; Teschke R
J Clin Transl Hepatol; 2018 Mar; 6(1):57-68. PubMed ID: 29577033
[TBL] [Abstract][Full Text] [Related]
19. Androgenic anabolic steroid-induced liver injury: two case reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature.
Abeles RD; Foxton M; Khan S; Goldin R; Smith B; Thursz MR; Verma S
BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33214235
[TBL] [Abstract][Full Text] [Related]
20. Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?
Shahbaz O; Mahajan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):935-951. PubMed ID: 28772086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
